China Manufacturer Roadmap for the Belarus Medical Device Market

1. Key takeaways

For Chinese manufacturers entering Belarus, the correct order is: first define and classify the product, then choose the registration path, and only then prepare the documentation. Local representation and language compliance are two workstreams that must be brought forward; they cannot be left until after document preparation. The logic behind the order is that each downstream decision depends on the upstream one: the classification determines the applicable scrutiny, the classification plus the target-market list determines the path, the path determines the document set and the timeline, and the representative and the language work sit underneath all of it as enabling conditions. A project that starts with translation or document assembly before these decisions are locked in will almost certainly face rework — and in a national procedure with a 90-calendar-day baseline, rework is not an inconvenience but a direct threat to the schedule that justified the path choice in the first place.

2. Legal basis

3. Expert insights

Insight 1: the window period is the single most important decision variable at present. The time window of the national procedure is benchmarked to 2027-12-31. A Chinese manufacturer that targets only the Belarusian market — 1 market — and wants to reach a sellable status as quickly as possible can reasonably start a national application inside the window; a manufacturer with multi-market plans should instead prepare the Union path in parallel. The two strategies are not exclusive, but they allocate the same budget differently, so the market list must be settled before the budget is. Waiting until the window is nearly closed to make this choice compresses every downstream task into an unrealistic schedule.

Insight 2: the 90-calendar-day baseline of Resolution No. 211 makes the national-path schedule calculable. This is a predictability advantage of Belarus relative to other markets. Chinese companies running parallel projects in China and Belarus can use this baseline to build a comparatively certain schedule for the Belarusian segment of the program, with defined review windows and defined response points. The predictability holds only if the incoming documentation is complete and the representative responds within the procedure’s own clock, so the schedule model must include the manufacturer-side tasks, not only the authority-side ones.

Insight 3: local representation is a strategic choice, not a procedural formality. The representative handles the filing, the replies to technical queries, the changes to the dossier, the post-market reporting and the maintenance of the certificate — and from 2026-07-30 must also liaise with Gosfarmnadzor on transferred post-market functions. The responsiveness of the representative directly determines whether the 90-day total time limit can be held, because queries that sit unanswered at the representative’s desk consume the same procedure clock as any other delay. Choosing a representative for price alone, without testing response capacity, is a false economy.

Insight 4: language and terminology unification must come first. Documents and labeling in Russian or Belarusian are a hard gate at the acceptance stage. The terminology table should be fixed before translation starts, so that core terms — product names, intended use, materials, specifications — are translated consistently across the dossier, the labeling and the instructions for use. Terminology drift discovered late forces retranslation of entire document sets and can push a filing outside a planned review cycle; fixing the table early is the cheapest quality control available in this project.

4. Practical recommendations

1. Proceed in the four steps of definition, classification, path selection and document preparation. Do not start large-scale document preparation until the first three steps are complete and recorded.
2. Fix the local representative at the project start stage. Write the scope of authorization in four segments — registration, changes, post-market and maintenance — so no obligation falls between two mandates.
3. Fix the terminology table before translation. Start the full translation only after the core terms have been finalized and signed off by both the technical and regulatory sides.
4. Write the three compliance milestones into the project master plan. The entry into force of No. 211 (2026-05-01), the entry into force of No. 378 (2026-07-30), and the window deadline (2027-12-31).

5. Verification checklist

• □ Product definition and classification into 1 / 2a / 2b / 3 have been completed
• □ The national or Union path has been determined according to the number of target markets
• □ The local representative has been appointed with authorization covering all four segments
• □ The core terminology table was fixed before translation began
• □ The three compliance milestones have been written into the project master plan

Regulatory information verified as of 30 October 2026.

In the Eurasian Economic Union market, GRZAN concentrates its core capabilities on three fronts. First, distinguishing the applicable conditions and the remaining time windows of the two channels — Union-level unified registration and national registration in each member state. The national registration procedure of Belarus has been fully restructured by Council of Ministers Resolution No. 211 of 28 April 2026 (state registration number 6-1/55925, in force 1 May 2026): the total time limit for preliminary technical work is compressed to 90 calendar days, the scope list is closed and implementing organizations are prohibited from expanding it, while the window for filing applications under the national procedure takes 31 December 2027 as the key milestone, so path selection must be decided in step with the time window. Second, local authorized representative services: GRZAN acts as the statutory representative of the manufacturer in Belarus, handling registration filings, responses to technical queries, changes to the registration dossier and post-market reporting obligations, and it has already synchronized its liaison mechanisms after Council of Ministers Resolution No. 378 of 27 July 2026 (in force 30 July 2026) transferred adverse event functions to the State Institution for State Pharmaceutical Supervision (Gosfarmnadzor). Third, quality system and testing support: GRZAN helps establish a quality management system conforming to ISO 13485 and organizes technical documentation according to the target path — the national path follows the annex to Ministry of Health Resolution No. 55, while the Union path follows Eurasian Economic Commission Council Decision No. 46. For post-market compliance in the Belarusian market — vigilance, recalls and responses to supervisory inspections — GRZAN provides end-to-end support built on the same framework.

Business enquiries: info@grzanglobal.com